متابعة
Peter Gennemark
Peter Gennemark
Researcher at AstraZeneca
بريد إلكتروني تم التحقق منه على astrazeneca.com
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Integrative model of the response of yeast to osmotic shock
E Klipp, B Nordlander, R Krüger, P Gennemark, S Hohmann
Nature biotechnology 23 (8), 975-982, 2005
5452005
Models from experiments: combinatorial drug perturbations of cancer cells
S Nelander, W Wang, B Nilsson, QB She, C Pratilas, N Rosen, ...
Molecular systems biology 4 (1), 216, 2008
2152008
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
R Jörnsten, T Abenius, T Kling, L Schmidt, E Johansson, TEM Nordling, ...
Molecular systems biology 7 (1), 486, 2011
1092011
An oral antisense oligonucleotide for PCSK9 inhibition
P Gennemark, K Walter, N Clemmensen, D Rekić, CAM Nilsson, ...
Science Translational Medicine 13 (593), eabe9117, 2021
1042021
Structural and functional characterization of a specific antidote for ticagrelor
A Buchanan, P Newton, S Pehrsson, T Inghardt, T Antonsson, ...
Blood, The Journal of the American Society of Hematology 125 (22), 3484-3490, 2015
1032015
PPARγ and PPARα synergize to induce robust browning of white fat in vivo
T Kroon, M Harms, S Maurer, L Bonnet, I Alexandersson, A Lindblom, ...
Molecular metabolism 36, 100964, 2020
702020
Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity
XR Peng, P Gennemark, G O’Mahony, S Bartesaghi
Frontiers in endocrinology 6, 174, 2015
692015
Efficient algorithms for ordinary differential equation model identification of biological systems
P Gennemark, D Wedelin
IET Systems Biology 1 (2), 120-129, 2007
692007
Benchmarks for identification of ordinary differential equations from time series data
P Gennemark, D Wedelin
Bioinformatics 25 (6), 780-786, 2009
642009
Discovery of (3-(4-(2-oxa-6-azaspiro [3.3] heptan-6-ylmethyl) phenoxy) azetidin-1-yl)(5-(4-methoxyphenyl)-1, 3, 4-oxadiazol-2-yl) methanone (AZD1979), a melanin concentrating …
A Johansson, C Lofberg, M Antonsson, S von Unge, MA Hayes, R Judkins, ...
Journal of Medicinal Chemistry 59 (6), 2497-2511, 2016
612016
A simple mathematical model of adaptation to high osmolarity in yeast
P Gennemark, B Nordlander, S Hohmann, D Wedelin
In silico biology 6 (3), 193-214, 2006
542006
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirin
S Pehrsson, KJ Johansson, A Janefeldt, AS Sandinge, S Maqbool, ...
Journal of Thrombosis and Haemostasis 15 (6), 1213-1222, 2017
302017
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
L Weidolf, A Björkbom, A Dahlén, M Elebring, P Gennemark, M Hölttä, ...
Drug discovery today 26 (10), 2244-2258, 2021
282021
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes
E Nyman, YJW Rozendaal, G Helmlinger, B Hamrén, MC Kjellsson, ...
Interface focus 6 (2), 20150075, 2016
212016
A modeling approach for compounds affecting body composition
P Gennemark, R Jansson-Löfmark, G Hyberg, M Wigstrand, D Kakol-Palm, ...
Journal of pharmacokinetics and pharmacodynamics 40, 651-667, 2013
212013
Digital twin predicting diet response before and after long-term fasting
O Silfvergren, C Simonsson, M Ekstedt, P Lundberg, P Gennemark, ...
PLOS Computational Biology 18 (9), e1010469, 2022
192022
Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs
K Ploj, L Benthem, D Kakol‐Palm, P Gennemark, L Andersson, M Bjursell, ...
British Journal of Pharmacology 173 (18), 2739-2751, 2016
192016
Formal representation of the high osmolarity glycerol pathway in yeast
C Kühn, KVS Prasad, E Klipp, P Gennemark
Genome Informatics 2009: Genome Informatics Series Vol. 22, 69-83, 2010
182010
Hybrid modelling for stroke care: Review and suggestions of new approaches for risk assessment and simulation of scenarios
T Herrgårdh, VI Madai, JD Kelleher, R Magnusson, M Gustafsson, ...
NeuroImage: Clinical 31, 102694, 2021
172021
Inhibition of the prostaglandin D2–GPR44/DP2 axis improves human islet survival and function
S Abadpour, B Tyrberg, SW Schive, CW Huldt, P Gennemark, E Ryberg, ...
Diabetologia 63, 1355-1367, 2020
162020
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20